Primary Site >> Pancreatic Cancer
Gene >> DCLK2
|
|
|---|---|
|
Ref: Population Pharmacokinetics of Gemcitabine and dFdU in Pancreatic Cancer Patients Using an Optimal Design, Sparse Sampling Approach. PMID: 28346313 |
Ref: Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance. PMID: 29780561 |